Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Prepaid Assets (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Prepaid Assets for 4 consecutive years, with $2.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets fell 69.51% year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Sep 2025, down 69.51%, and an annual FY2024 reading of $10.1 million, up 63.57% over the prior year.
  • Prepaid Assets was $2.8 million for Q3 2025 at Atara Biotherapeutics, up from $2.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $16.0 million in Q3 2022 and bottomed at $2.4 million in Q2 2025.
  • Average Prepaid Assets over 4 years is $8.9 million, with a median of $9.4 million recorded in 2023.
  • The sharpest move saw Prepaid Assets skyrocketed 63.57% in 2024, then tumbled 69.51% in 2025.
  • Year by year, Prepaid Assets stood at $10.3 million in 2022, then crashed by 40.01% to $6.2 million in 2023, then skyrocketed by 63.57% to $10.1 million in 2024, then tumbled by 72.25% to $2.8 million in 2025.
  • Business Quant data shows Prepaid Assets for ATRA at $2.8 million in Q3 2025, $2.4 million in Q2 2025, and $4.3 million in Q1 2025.